It may therefore be assumed that decreased vitamin K-dependent carboxylation of MGP in PXE patients results in decreased inhibition of BMP-2, which then, through its main SMAD-mediated signaling pathway, causes a shift towards an osteogenic phenotype in fibroblasts and VSMCs (Figure 2). This evidence concerns the gene BMP2 and Pseudoxanthoma elasticum.